Wilkins, E. L., Cohen, C. J., Trottier, B., Esser, S., Smith, D. E., Haas, B., Brinson, C., Garner, W., Chuck, S., Thorpe, D., & De-Oertel, S. (2016). patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment. AIDS care, 28(3), 401–408. http://access.bl.uk/ark:/81055/vdc_100028819188.0x00002b